Biomedical engineers use iPSCs to grow specialized retinal endothelial cells, successfully regenerating damaged eye blood ...

The breakthrough shows promise for new eye therapies, say American scientists. Biomedical engineers at Duke University, North ...

Biomedical engineers at Duke University have used induced pluripotent stem cells (iPSCs) to grow specialized blood vessel ...

Biomedical engineers at Duke University have used induced pluripotent stem cells (iPSCs) to grow specialized blood vessel cells critical to retinal health for the first time. When injected into mouse ...

Scientists in America have carried out significant new research ...

Blind people have been given renewed hope of regaining their sight after laboratory-cultivated cells restored retinal ...

Preclinical study showed iRECs Integrated into host vascular network and revascularized the ischemic eye, rescuing the tissue.

It could 'pave the way for new therapeutic approaches.' ...

Human iPSCs are a new type of pluripotent cell reprogrammed from patient or donor cells into versatile stem cells that can become any cell type. These iPSC-derived cells, which retain disease ...

A California-based company says it has created the world's first early-stage human egg cells from stem cells using lab-grown ...

Aspen Neuroscience, Inc., a clinical-stage regenerative medicine biotechnology company developing personalized, autologous cell therapies, today announced completion of dosing in Cohort 3 and Cohort 4 ...

Researchers at Karolinska Institutet have demonstrated that it is possible to create early germ cells from preserved ...